Abstract. In a previous study, we found that magnesium deficiency stimulated prostacyclin production and suggested that this stimulation resulted from an enhanced Ca 2+ influx induced by magnesium deficiency. In this study, we further examined prostacyclin generation in cultured human umbilical vein endothelial cells after intracellular free calcium content ([Ca 2+ ] i ) was altered by addition of diltiazem, nifedipine, verapamil, sodium cyanide (NaCN), ruthenium red or quinidine to a low magnesium medium. The results showed that diltiazem, nifedipine, verapamil and ruthenium red inhibited 45 Ca 2+ influx, and NaCN and quinidine had no effect on 45 3 H]arachidonic acid content in cellular phospholipids caused by low magnesium treatment was not altered by the added compounds. We suggested that arachidonic acid release and prostacyclin production was calcium-dependent in cultured endothelial cells.
Prostacyclin, a strong vasodilator and the most powerful inhibitor of platelet aggregation known, plays an important role in maintaining normal homeostasis. Prostacyclin is produced from arachidonic acid, which is available in small amounts under normal physiological conditions and liberated from the phospholipids by phospholipase A 2 (PLA 2 ) action when it is needed [1, 2] . PLA 2 is believed to catalyze the rate-limiting step in prostaglandin biosynthesis in most tissues [3] . The cyclooxygenases, another family of rate-limiting enzymes involved in the synthesis pathways of prostaglandins, metabolize arachidonic acid to prostaglandin H 2 , the common substrate for the synthesis of biologically-active products such as thromboxane, prostacyclin and prostaglandin E 2 [4] . Both PLA 2 and cyclooxygenases have been shown to be Ca 2+ -dependent [3, 5] . The major product in endothelial cells is prostacyclin, chiefly preventing thrombus formation by inhibiting platelet activation [6] .
Endothelial cells in the cardiovascular system play key regulatory roles by producing several potent vasoactive agents and regulating coagulation states [7] . Most endothelial functions depend to various extents on changes in intracellular free Ca 2+ concentrations ([Ca 2+ ] i ) [8] . Magnesium is nature's calcium channel blocker [9] as shown by inhibition of Ca 2+ receptor-and voltage-dependent channels [10] . Magnesium has been demonstrated to regulate basal tone and contractile responsiveness of vascular smooth muscle cells to various physiological and pharmacological stimuli [10] [11] [12] [13] . Moreover, magnesium is essential for the activation over 300 different enzyme systems critical to life [14] . It is also essential in the glycolytic cycle that converts sugar to adenosine triphosphate (ATP) [15] . Magnesium is intimately involved in nucleic acid metabolism; it plays key roles in the second messenger systems that mediate hormonal effects on cells, and is a major controller of cellular ion channels, governing the flow of sodium, potassium and calcium in and out of cells [15] . It is also involved in plasma membrane phospholipid metabolism [16] [17] [18] [19] . The altered concentration of phospholipids as a result of magnesium deficiency further affects the conformation and function of membrane-bound proteins, such as ion channels, ion pumps and receptors [16] , resulting in a change in Ca 2+ influx, Ca 2+ efflux, and Ca 2+ release from intracellular stores.
To provide protection against intracellular magnesium depletion and [Ca 2+ ] i accumulation so as to counteract the constricted and hyperreactive state of the vasculature under magnesium deficiency conditions [20, 21] , prostacyclin production was stimulated [20, 22] , and PLA 2 and cyclooxygenase activities enhanced [22] . Since the activities of most phospholipases and cyclooxygenases are Ca 2+ -dependent [23] , we were interested to find out how low magnesium in culture medium increased [Ca 2+ ] i . In this study, we used seven compounds known to influence Ca 2+ transport in membranes: diltiazem, nifedipine and verapamil (inhibitors of Ca 2+ influx via inhibition of a voltage-dependent calcium channel [24] ), ruthenium red (a potent blocker of Ca 2+ influx [25] ), quinidine (an inhibitor of Ca 2+ efflux that acts by inhibiting Na + /Ca 2+ exchange [26] ), and NaCN (an inhibitor of mitochondrial respiration [27] ), resulting in decreased energy production, thereby affecting calcium homeostasis).
Materials and Methods

Materials
Arachidonic acid [5, 6, 8, 9, 11, 12, 14, Fura-2/AM was obtained from Molecular Probes Inc. Stock solutions of 1 mM Fura-2/AM were prepared with chloroform, dried under nitrogen and stored at -20
• C. Working solutions were prepared immediately before use by diluting stored Fura-2/AM in dimethylsulfoxide (DMSO) and then by dilution to 1.5 M in a balanced salt solution (BSS). The BSS contained 20 mM HEPES buffered to pH 7.4 with Tris base, 135 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10 mM glucose and 0.025% bovine serum albumin (BSA).
Cell culture
Human umbilical endothelial cells were obtained from ATCC (Rockville, MA, USA) and used between passages 4 to 11. The cells were cultured in MEM supplemented with 10% FBS in a 5% CO 2 incubator at 37
• C. When the cells grew to 70% confluence, they were cultured with [ 3 H]arachidonic acid (0.2 Ci/mL) in MEM containing 5% FBS for 24 h. After the cells were washed five times with MEM containing 0.125 mM BSA, they were cultured in MEM-5% FBS containing magnesium at a concentration of 95 M with/without 5 M of diltiazem, nifedipine, verapamil, ruthenium red, quinidine or NaCN. A medium containing 949 M of magnesium was used as a control since the magnesium concentration in the culture medium with FBS used was 949 M. The following experiments were then performed.
Measurement of [ 3 H]arachidonic acid release
After the cells were cultured in 12-well plates with 2.5 mL of a medium containing magnesium at 95 M for 1, 4, 6, 12 and 24 h, 200 L of the culture media were collected, centrifuged at 2,000 g for 10 mn, and 150 L of the supernatant counted for radioactivity [28] . At the end of the incubating period, the cells were digested in 1 mL of 0.1 N NaOH and the protein concentrations in the cells were determined (Bio-Rad, Hercules, CA, USA).
Analysis of prostacyclin production
The cells were cultured in six-well plates with 3 mL of a medium containing magnesium at 95 M for 24 h. The culture media were then collected, and treated as follows [29] . In brief, the media were acidified to pH 3.5 with 1 M citric acid, and extracted twice with two volumes of ethyl acetate following addition of NaCl. Aliquots of the ethyl acetate extract were separated by TLC using ethyl acetate:acetic acid:2,2,4-trimethyl pentane:H 2 0 (110:20:50:100). The spots of 6-keto-PGF 1␣ on the plates were collected and the radioactivity in these spots was counted. The nonspecific activities obtained from some silica gel on blank spaces were subtracted from sample radioactivity. The cells were digested in 1 mL of 0.1 N NaOH, and the protein concentrations in the cells determined.
Determination of the remaining [ 3 H]arachidonic acid in phospholipids
After a 24 h culture of the cells in 75 cm 2 flasks, the media were aspirated and the cells were rinsed, trypsinized, collected and sonicated [30] . Aliquots were taken for protein assay and lipids were extracted [30] . The lipid extracts were separated by TLC using chloroform:methanol:acetic acid:water (25:15:4:2, v:v:v:v). The spots of the phospholipid fractions on the plates were collected and radioactivity counted. The nonspecific activities on silica gel plates and protein concentrations from the cells were obtained for calculation.
Measurement of intracellular free Ca
2+ with Fura-2/AM
After the cells were incubated in 25 cm 2 flasks (without exposure to [ 3 H]arachidonic acid) in a medium containing magnesium at 95 M for 24 h, the vesicle suspensions were aspirated from the culture flasks and the cells were washed three times with 4 mL of MEM. Then, 4 mL of 1.5 M Fura-2/AM were added to each flask, and the culture incubated at 37
• C for 60 min. The medium was removed from the flasks and the culture washed three times with 4 mL of BSS. The cells were removed from the flasks by incubation with trypsin for 1 min followed by scraping with a rubber policeman. They were then washed three times with ice-cold BSS and then centrifuged at 250 g for 3 min after each washing to remove trypsin and extracellular Fura-2/AM. The cells were then suspended in 3 mL of BSS on ice and 2.5 mL aliquots of cell suspension were placed in 1 cm quartz cuvettes for measurement of intracellular free Ca 2+ with continuous stirring at room temperature. The samples were excited alternately at 340 and 380 nm (bandwidth=5 nm) and fluorescence emission intensity was monitored continuously at 510 nm (bandwidth= 5 nm). F max and F min were obtained by addition of 8 L of 100% Triton X-100 and 150 L of 400 mM EGTA, respectively. Intracellular free Ca 2+ was calculated from the fluorescence signals as described by Grynkiewicz et al. [31] . Autofluorescence was determined in samples of the cells treated with 15 L DMSO without Fura-2/AM. No leakage of the dye outside the cells was noted as evaluated by addition of 1 mM Mn 2+ to the cell suspension just before recording the spectra.
Measurement of 45 Ca 2+ influx
The cells, without treatment with [ 3 H]arachidonic acid, seeded in 24-well plates were incubated with magnesium at 95 M for 24 h and then with 1 Ci 45 Ca 2+ in 0.5 mL for 1 h. The monolayers were washed three times with ice-cold, 0.1% phosphatebuffered saline (PBS) containing 1 mM EGTA and digested in 1 mL of 0.1 N NaOH; 0.7 ml of the digested cells were counted in a liquid scintillation counter and 0.1 mL was assayed for protein.
Data analysis
Data were subjected to ANOVA, and Student's and Newman-Keuls tests. Differences with p < 0.05 were considered significant. All data are presented as mean ± SE.
Results
The addition of diltiazem, nifedipine, verapamil, ruthenium red, quinidine or NaCN to the culture medium containing a physiological concentration of magnesium (949 M) had no effect on [ 3 H]arachidonic acid release ( figure 1A ) and [Ca 2+ ] i (figure 1B) until 24 h. However, when these compounds were added to a medium containing magnesium at 95 M, they evoked a marked figure 2A , there was a significant, time-dependent increase in [ 3 H]arachidonic acid release when cells were incubated in a medium containing 95 M of magnesium. The release from these cells increased from 159 ± 15 to 185 ± 10 DPM/mg of protein after a 1-h incubation, and from 407 ± 30 to 530 ± 14 DPM/mg of protein after a 24-h incubation. This increase was significantly inhibited by addition of diltiazem, nifedipine, verapamil, ruthenium red, quinidine or NaCN ( figure 2B) . The decreases in release ranged from 135 ± 12 to 162 ± 11 DPM/mg of protein after a 1-h incubation, and from 339 ± 21 to 445 ± 25 DPM/mg of protein after 24-h incubation. Statistical analysis indicated that the reductions in [
3 H]arachidonic acid release caused by these compounds were significant for all of the measured incubating periods.
Prostacyclin is quantitatively converted to 6-keto-PGF 1␣ and the latter is chemically stable and biologically less active, so 6-keto-PGF 1␣ was used as a measure of prostacyclin synthesis. We found that 6-keto-PGF 1␣ production was increased from 356 ± 25 to 584 ± 41 DPM/mg of protein in the cells cultured for 24 h in a medium containing 95 M of magnesium ( figure 3) . The increased production of 6-keto-PGF 1␣ was significantly reduced to within a range of 325 ± 17 to 425 ± 31 DPM/mg of protein by addition of these compounds to the culture medium.
We investigated the effect of diltiazem, nifedipine, verapamil, ruthenium red, quinidine and NaCN on Ca 2+ influx into the cells by using 45 Ca 2+ after 24-h incubation periods. Figure 4A shows that incubation in 95 M magnesium medium evoked a significant increase (1020 ± 52 CPM/g protein) in 45 Ca 2+ uptake in comparison with the cells incubated in 949 M magnesium medium (762 ± 46 CPM/g of protein). After addition of the voltage-dependent Ca 2+ channel inhibitors, diltiazem, nifedipine, and verapamil, this increase was significantly reduced to within a range of 638 ± 21 to 740 ± 32 CPM/g of protein. An interesting finding in this study was that ruthenium red was able to decrease 45 Ca 2+ influx. Quinidine and NaCN had no effect on 45 Ca 2+ influx. 
Discussion
We reported in our previous study that an increase in arachidonic acid release and prostacyclin production was induced by a medium containing low magnesium levels [22] . This increase was accompanied by an enhancement of Ca 2+ influx. Here, we have also found that when a compound that can affect Ca 2+ transport was added, the increase in [ 3 H]arachidonic acid release and prostacyclin production by low magnesium was reduced. This reduction could not be explained by the lack of an arachidonic acid supply, because the concentration of [ 3 H]arachidonic acid in cellular phospholipids was no different in the groups with/without treatment with a compound.
The calcium-entry blockers, verapamil, diltiazem and nifedipine had an effect on the enhanced Ca 2+ influx caused by low magnesium. Our data showed that verapamil, diltiazem and nifedipine reduced the low magnesium-induced increase in 45 Ca 2+ influx and [Ca 2+ ] i , and inhibited arachidonic acid release and prostacyclin production. In different experimental models, verapamil and diltiazem were showed to be able to inhibit Ca 2+ influx [32] and prostaglandin production [33] . A calcium-transporting ionophore, A23187, stimulated prostaglandin production only in the presence of Ca 2+ [34] . All of these findings indicated that the increased Ca 2+ influx through voltage-dependent Ca 2+ channel was involved in mediation of the low magnesium-induced increase in prostacyclin production. Our results show that NaCN had no effect on the stimulated 45 A report indicating that blocking the ryanodine receptor, another Ca 2+ release channel on the endoplasmic reticulum in endothelial cells [35] , affected the NaCN-induced change in [Ca 2+ ] i [36] suggested to us that ryanodine-activated calcium release channels could be involved in the low magnesium-induced increase in [Ca 2+ ] i . NaCN was reported to affect calcium homeostasis, but its effect was dose-dependent. For example, 10 mM of NaCN in culture medium induced a transient increase in [Ca 2+ ] i [36, 37] . When the dose of NaCN was reduced to 2 mM, NaCN could either increase or decrease the magnitude of the Ca 2+ transient [38] . After the dose of NaCN was further reduced to 10 M, the dose used in this study, decreased [ [41] , and on ryanodine-activated calcium release channels [42] . In this study, we found that ruthenium red inhibited 45 Ca 2+ influx. Ruthenium red has been demonstrated to inhibit both the first fast phase of Ca 2+ influx (Ca 2+ binding to the cell surface), and the second slow phase of Ca 2+ influx (the intracellular compartment size for Ca 2+ store) [41] . Ruthenium red could also block ryanodine-activated calcium release channels [42] , resulting in a decrease in [Ca 2+ ] i . When ryanodine receptors were combined with ryanodine, Ca 2+ release from this channel was trigged [43] . This combination could be blocked by ruthenium red [42] . All of these actions of ruthenium red, in both extracellular and intracellular sites [41, 44] , proved that the increased [Ca 2+ ] i induced by low magnesium resulted from the stimulated Ca 2+ influx and Ca 2+ release from intracellular stores.
When the low magnesium-induced increases in [Ca 2+ ] i were diminished by these compounds, the enhanced prostacyclin production by low magnesium was reduced. However, we could not exclude possible direct effects of these compounds on prostacyclin production. For example, ruthenium red inhibited phospholipase A 2 through inhibition of the binding of Ca 2+ to calmodulin [45] ; a decreased ATP production caused by NaCN and quinidine may affect prostacyclin production because ATP and ADP stimulated a release of prostacyclin from bovine aortic endothelial cells [46] [47] [48] ; NaCN inhibited cyclooxygenase [49] . Since the investigation of these compounds is beyond the scope of this study, we would not attempt further discussion here.
Conclusion
With the compounds tested, we found that the increase in [Ca 2+ ] i induced by low magnesium resulted from both a stimulated Ca 2+ influx and an enhanced Ca 2+ release from intracellular stores. The data showing that a change in [Ca 2+ ] i , regardless of its cause, could affect arachidonic acid release and prostacyclin production indicated that prostacyclin production was Ca 2+ -dependent in cultured vascular endothelial cells. The increased production of prostacyclin, which has anti-atherogenic and anti-thrombotic effects, can counteract the cardiovascular effects of thromboxane.
